Biomea Fusion, Inc. (BMEA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 12.78 |
| Open | 12.85 |
| Bid | 12.21 x 200 |
| Ask | 12.26 x 100 |
| Day's range | 12.17 - 12.85 |
| 52-week range | 8.12 - 43.69 |
| Volume | |
| Avg. volume | 1,009,993 |
| Market cap | 439.962M |
| Beta (5Y monthly) | -0.35 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
We're Keeping An Eye On Biomea Fusion's (NASDAQ:BMEA) Cash Burn Rate
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
- Zacks
Biomea Fusion (BMEA) Stock Surges 41% in a Month: Here's Why
Biomea Fusion (BMEA) rises 41% in a month on the back of positive investor expectations regarding the clinical development of its lead candidate, BMF-219, for the type II diabetes indication.
- Zacks
Biomea (BMEA) Doses First Patient in Leukemia Study, Stock Up
Biomea (BMEA) successfully doses the first patient in its phase I study of BMF-500 to treat adult patients with acute leukemia. The company's stock rises 6.7% on the news.
© 2024 Yahoo. All rights reserved.